In an attempt to find potential transcript factors that may play a role in increased ASPM expression in gliomas, we predicted several potential FoxM1 binding sites in ASPM promoter using transcript factor binding site prediction databases. This evidence concerns the gene FOXM1 and central nervous system cancer.